Patient Guide: Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 70 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07165951
Status: NOT_YET_RECRUITING
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 70 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Hefei, Anhui
  • Hefei, Anhui
  • Beijing, Beijing Municipality
  • • And 67 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily